148 related articles for article (PubMed ID: 31608998)
1. LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP-mediated pathway.
Lou C; Zhao J; Gu Y; Li Q; Tang S; Wu Y; Tang J; Zhang C; Li Z; Zhang Y
J Cell Physiol; 2020 Apr; 235(4):3928-3938. PubMed ID: 31608998
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression.
Chen X; Wang J; Xie F; Mou T; Zhong P; Hua H; Liu P; Yang Q
Aging (Albany NY); 2020 Jul; 12(14):14452-14466. PubMed ID: 32678071
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
Liu S; Yang Y; Wang W; Pan X
J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
[TBL] [Abstract][Full Text] [Related]
4. lncRNA
Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression.
Yang X; Yang Y; Qian X; Xu X; Lv P
Biomed J; 2022 Jun; 45(3):512-521. PubMed ID: 35715331
[TBL] [Abstract][Full Text] [Related]
7. LINC01559 promotes colorectal cancer via sponging miR-1343-3p to modulate PARP1/PTEN/AKT pathway.
Li H; Liu J; Lai Y; Huang S; Zheng L; Fan N
Pathol Res Pract; 2021 Aug; 224():153521. PubMed ID: 34329839
[TBL] [Abstract][Full Text] [Related]
8. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.
Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M
J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251
[TBL] [Abstract][Full Text] [Related]
9. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.
Wang Q; Ding J; Nan G; Lyu Y; Ni G
J Cell Biochem; 2019 Oct; 120(10):16913-16920. PubMed ID: 31099044
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
12. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
[TBL] [Abstract][Full Text] [Related]
13. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
[TBL] [Abstract][Full Text] [Related]
14. ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression.
Shen H; Zhu H; Chen Y; Shen Z; Qiu W; Qian C; Zhang J
Cell Death Dis; 2021 Apr; 12(4):349. PubMed ID: 33824282
[TBL] [Abstract][Full Text] [Related]
15. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.
Chen B; Li Q; Zhou Y; Wang X; Zhang Q; Wang Y; Zhuang H; Jiang X; Xiong W
Cell Cycle; 2018; 17(16):1949-1966. PubMed ID: 30300116
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway.
Lei S; He Z; Chen T; Guo X; Zeng Z; Shen Y; Jiang J
J Exp Clin Cancer Res; 2019 Nov; 38(1):470. PubMed ID: 31747939
[TBL] [Abstract][Full Text] [Related]
17. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
[TBL] [Abstract][Full Text] [Related]
18. UCA1 Regulates the Growth and Metastasis of Pancreatic Cancer by Sponging miR-135a.
Zhang X; Gao F; Zhou L; Wang H; Shi G; Tan X
Oncol Res; 2017 Nov; 25(9):1529-1541. PubMed ID: 28315290
[TBL] [Abstract][Full Text] [Related]
19. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
20. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
